We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App

New Technique Reveals Earliest Signs of Genetic Mutations

By LabMedica International staff writers
Posted on 14 Jun 2024
Print article
Image: The Hairpin Duplex Enhanced Fidelity Sequencing (HiDEF-seq) could reveal the causes of mutations (Photo courtesy of Shutterstock)
Image: The Hairpin Duplex Enhanced Fidelity Sequencing (HiDEF-seq) could reveal the causes of mutations (Photo courtesy of Shutterstock)

Mutations are alterations in the molecular "letters" that constitute the DNA code, which serves as the blueprint for all living cells. While some of these changes may be inconsequential, others can lead to serious diseases, including cancer. Now, a new study has introduced a groundbreaking technique that can accurately identify early molecular changes in the DNA code that precede mutations. This new method could enhance our understanding of the fundamental causes of mutations in both healthy and cancerous cells, as well as how genetic changes accumulate naturally in human cells as individuals age.

The technique, known as HiDEF-seq (Hairpin Duplex Enhanced Fidelity Sequencing), was developed by researchers at NYU Langone Health (New York, NY, USA), along with collaborators across North America and in Denmark. It focuses on resolving the initial stages of mutation occurring in DNA. DNA consists of two strands, each made up of molecular letters or bases: adenine (A), thymine (T), guanine (G), and cytosine (C). The bases on one strand pair specifically with those on the other, with A pairing with T and G pairing with C, which ensures the DNA code is replicated accurately and transmitted from one cell generation to the next. Notably, mutations are alterations that appear in the DNA on both strands; for example, a G-C base pair might mutate into an A-T base pair.

However, the researchers point out that most mutations originate from changes that occur in just one of the DNA strands, such as a mismatched G-T base pair. These single-strand changes, which previous testing methods could not precisely identify, may happen when a DNA strand is incorrectly copied during cell division or when a strand is damaged by heat or chemicals in the body. If these single-strand DNA changes are not repaired by the cell, they can become fixed and evolve into permanent double-strand mutations. The HiDEF-seq technique has demonstrated exceptional accuracy in detecting double-strand mutations, with an estimated error rate of only one in every 100 trillion base pairs analyzed. Importantly, HiDEF-seq can detect changes in the DNA code while they are still present on only one of the DNA strands before they change into permanent double-strand mutations.

"Our new HiDEF-seq sequencing technique allows us to see the earliest fingerprints of molecular changes in DNA when the changes are only in single strands of DNA," said senior study author Gilad Evrony, MD, PhD, a core member of the Center for Human Genetics & Genomics at NYU Grossman School of Medicine. "Our study lays the foundation for using the HiDEF-seq technique in future experiments to transform our understanding of how DNA damage and mutations arise. Our long-term goal is to use HiDEF-seq to create a comprehensive catalogue of single-strand DNA mismatch and damage patterns that will help explain the known double-strand mutation patterns. In the future, we hope to combine profiling of single-strand DNA lesions, as obtained from HiDEF-seq, with the lesions' resulting double-strand mutations to better understand and monitor the everyday effects on DNA from environmental exposures." The study was published in Nature on June 12, 2024.

Related Links:
NYU Grossman School of Medicine

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Helicobacter Pylori Test

Print article


Clinical Chemistry

view channel
Image: The new DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer (Photo courtesy of Beckman Coulter Diagnostics)

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability

As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.